
The three departments issued an announcement regarding the connection of preferential policies for import value-added tax after the implementation of the Value-Added Tax Law
36Kr learned that the Ministry of Finance, the General Administration of Customs, and the State Administration of Taxation issued an announcement regarding the connection of preferential policies for import value-added tax after the implementation of the Value-Added Tax Law. The preferential policies for import value-added tax in the "Notice on Value-Added Tax Policies for Anti-Cancer Drugs" (CaiShui [2018] No. 47) and the "Notice on Value-Added Tax Policies for Rare Disease Drugs" (CaiShui [2019] No. 24) will continue to be implemented from January 1, 2026, to December 31, 2027. Other import value-added tax preferential policies and related supporting documents that were implemented before the Value-Added Tax Law came into effect and have an expiration date after January 1, 2026, will continue to be executed according to the original regulations

